Sponsor:
Sight Medical Doctors PLLC
Code:
NCT04863742
Conditions
Dry Eye Syndromes
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dextenza 0.4Mg Ophthalmic Insert
Prednisolone Acetate
Brief summary:
Conditions
Dry Eye Syndromes
Study ID
NCT04863742
Start date
Apr 26, 2021
Status verified date
Apr, 2021
Completion date
Sep 30, 2021
Anticipated
Primary completion date
Jul 31, 2021
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Dextenza Arm
active comparator: Prednisolone Acetate 1%
Interventions
Dextenza 0.4Mg Ophthalmic Insert
Prednisolone Acetate
Primary outcome measure
Central contacts
Locations
SightMD, LIASC
Recruiting
Brentwood, New York, United States, 11717
Contacts
Sponsor
Sight Medical Doctors PLLC
Last update posted
Apr 28, 2021
Last verified
Apr, 2021
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Sight Medical Doctors PLLC on 2021-04-28.